Infertility Awareness Week marks 35 years of ART advancements

Sam Prien, Ph.D.
Infertility Awareness Week, April 21 through April 27, is a week devoted to raising awareness of the estimated one in six couples who suffer infertility issues. For those who work in the field of infertility treatment, the dedicated doctors, nurses, and, like me, the guys back in the lab, it is a time to reflect on where we have come from, where we are and where we hope to go.
This year has a special significance because it marked the 35th anniversary of the first birth from what has become known as assisted reproductive technologies (ART) associated with the infertility program at Texas Tech University Health Sciences Center (TTUHSC). That birth was approximately a decade after the first test tube baby was born in 1978. While the news surrounding this was not as earth-shattering, it made headlines from Lubbock to Dallas as the first baby conceived using high-tech procedures in West Texas. The fact that it made the news was a testament to how little progress was made in the first ten years of ART use in humans; almost every birth was a major announcement because pregnancy rates then were a dismal 7%.
In the 1990s, the world of infertility began to change with new techniques such as the single sperm injection technique and intracytoplasmic sperm injection (ICSI). These techniques, combined with more standardized treatment plans and better overall culture conditions in the laboratory, led to drastically higher pregnancy rates, which rose from 7 to 35% by the end of the last century to national and local rates approaching 50% in some patient populations. The procedure has become so routine that 2 to 3% of the annual birth rate in the U.S. is associated with infertility treatment.
These successes have not come without their growing pains, as what were wonderous birth announcements in the news now focus on clinic mistakes or accidents. However, ART treatment has become a safe and effective means for those with infertility issues. Newer techniques are allowing us to transfer embryos with the best chance of having a healthy pregnancy and healthy baby, lowering the number of procedures a couple has to undergo to take home the child they always wanted.
So, what is the future? In the 1990s, when the TTUHSC program had one of the highest take-home baby rates of about 30%, I was asked if I was proud. I answered, “No, that means two out of three couples are going home without a baby.” We are at 50% now, but that still means only half take home a baby though we have become better in certain areas of fertility treatment. For example, we now routinely transfer only a single embryo, which is why the birth of triplets, quadruplets, quintuplets, or more has become increasingly rare. Singleton pregnancies have much better outcomes. Yet, other areas, such as selecting the healthiest sperm from a population of millions, a focus of TTUHSC fertility research, and which might be the next major step in driving take-home baby rates up into the 60 to 70% range, still elude us.
Yes, Infertility Awareness Week is an excellent reminder of the many struggles faced by couples having difficulty conceiving. Well beyond the simple mechanical issues of conception, there are the financial and emotional issues these couples face along their fertility journey. Yet there are now many stories of success as improvements in ART lead to more couples taking home the babies they always wanted. After almost 40 years of continuous existence, the fertility program at TTUHSC has assisted in the conception and birth of thousands of children in West Texas. In fact, I’ve had the privilege of teaching numerous students at the university who were conceived with the help of our program. Some of them have even participated in our research to improve ART techniques. Life really does go full circle.
Sam Prien, Ph.D., is a professor and director of Clinical and Research Laboratories in the TTUHSC School of Medicine Department of Obstetrics and Gynecology. This editorial was written for and originally published by the Lubbock Avalanche-Journal.
Related Stories
Your Office Squad: A How to Guide
Lynn Jennings, PhD, LPC-S, LSOTP-S, and Nicole Noble, PhD, LPC-S, joined the TTU Health Check podcast to share their expertise and advice on fostering connections in the workplace.
New Year, New You
Patti May, M.D., family medicine, Texas Tech Physicians Multispecialty Clinic, explains the different procedures available to help older and younger people look refreshed.
New Procedure Offers Hope for COPD Sufferers in the Panhandle
For those who have successfully quit smoking but may have significant limitations from the residual lung damage associated with emphysema, a new medical procedure called Bronchoscopic Lung Volume Reduction (BLVR) is now available in Amarillo.
Recent Stories
ASCO GU Symposium Announces New Findings on Tumor Reduction and Survival Outcomes in Advanced Renal Cell Carcinoma
Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at TTUHSC and director of the UMC Cancer Center, shared groundbreaking findings from the landmark CLEAR study.
Guest Named Abilene Regional Dean of the Texas Tech University Health Sciences Center School of Nursing
Heather Guest, Ph.D., R.N., has been named the Texas Tech University Health Sciences Center (TTUHSC) School of Nursing regional dean in Abilene. TTUHSC School of Nursing Dean Holly Wei, Ph.D., R.N., made the announcement, effective Jan. 1, 2025.
Researcher Develops Method to Measure Blood-Brain Barrier Permeability Accurately
Quentin R. Smith, Ph.D., from the Department of Pharmaceutical Sciences at the TTUHSC Jerry H. Hodge School of Pharmacy, sought to reconcile discrepancies in the field and provide accurate methods for measuring permeability over a very broad range.